Study Title: Phase II Study of the Combination of Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
 

• Status: Terminated

• Participating Sites:
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Rutgers Cancer Institute of New Jersey
  • University of Wisconsin Carbone Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT03997448
  • Big Ten CRC News Release
• Publications and Presentations:
  • Trials in Progress Poster Session: 2020 Gastrointestinal Cancers Symposium